Generic Name: Evolocumab
Brand Name: Repatha
Manufacturer: Amgen Canada Inc.
Indications: Primary hyperlipidemia and mixed dyslipidemia
Submission Type: Resubmission
Project Status: Complete
Biosimilar: No
Date Recommendation Issued: November 22, 2017
Recommendation Type: Reimburse with clinical criteria and/or conditions